Hereditary angioedema type 1, limitations for prophylactic therapy with Lanadelumab: Regarding a case. Rev Alerg Mex [Internet]. 2024 Dec. 30 [cited 2026 Sep. 23];71(4):264-7. Available from: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1323